Target Price | €26.65 |
Price | €19.80 |
Potential | 34.57% |
Number of Estimates | 17 |
17 Analysts have issued a price target Bayer 2025 . The average Bayer target price is €26.65. This is 34.57% higher than the current stock price. The highest price target is €37.00 86.85% , the lowest is €22.00 11.10% . | |
A rating was issued by 19 analysts: 4 Analysts recommend Bayer to buy, 15 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Bayer stock has an average upside potential 2025 of 34.57% . Most analysts recommend the Bayer stock at Hold. |
16 Analysts have issued a sales forecast Bayer 2024 . The average Bayer sales estimate is €46.3b . This is 0.86% lower than the revenue of the last 12 months(TTM). The highest sales forecast is €47.5b 1.73% , the lowest is €45.8b 2.12% .
This results in the following potential growth metrics:
2023 | €47.6b | 6.11% |
---|---|---|
2024 | €46.3b | 2.73% |
2025 | €46.6b | 0.54% |
2026 | €47.5b | 1.95% |
2027 | €48.2b | 1.41% |
2028 | €49.3b | 2.28% |
16 Analysts have issued an Bayer EBITDA forecast 2024. The average Bayer EBITDA estimate is €10.1b . This is 8.68% lower than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is €10.9b 2.06% , the lowest is €9.9b 10.50% .
This results in the following potential growth metrics and future EBITDA Margins:
2023 | €12.3b | 1.26% |
---|---|---|
2024 | €10.1b | 17.79% |
2025 | €9.8b | 3.01% |
2026 | €10.3b | 4.54% |
2027 | €10.2b | 0.82% |
2028 | €11.0b | 7.70% |
2023 | 25.91% | 7.86% |
---|---|---|
2024 | 21.90% | 15.47% |
2025 | 21.12% | 3.56% |
2026 | 21.66% | 2.56% |
2027 | 21.18% | 2.22% |
2028 | 22.30% | 5.29% |
10 Bayer Analysts have issued a net profit forecast 2024. The average Bayer net profit estimate is €837m . This is 194.72% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is €3.6b 512.22% , the lowest is €-1.9b 120.00% .
This results in the following potential growth metrics and future Net Margins:
2023 | €-2.9b | 170.85% |
---|---|---|
2024 | €837m | 128.51% |
2025 | €2.6b | 207.97% |
2026 | €3.0b | 16.67% |
2027 | €3.4b | 13.39% |
2028 | €3.8b | 12.71% |
2023 | -6.17% | 175.47% |
---|---|---|
2024 | 1.81% | 129.35% |
2025 | 5.54% | 206.08% |
2026 | 6.34% | 14.44% |
2027 | 7.08% | 11.67% |
2028 | 7.81% | 10.31% |
10 Analysts have issued a Bayer forecast for earnings per share. The average Bayer <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is €0.85 . This is 194.44% higher than earnings per share in the financial year 2023. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is €3.71 512.22% , the lowest is €-1.98 120.00% .
This results in the following potential growth metrics and future valuations:
2023 | €-2.99 | 170.85% |
---|---|---|
2024 | €0.85 | 128.43% |
2025 | €2.63 | 209.41% |
2026 | €3.06 | 16.35% |
2027 | €3.47 | 13.40% |
2028 | €3.91 | 12.68% |
Current | -22.11 | 99.19% |
---|---|---|
2024 | 23.23 | 205.07% |
2025 | 7.54 | 67.54% |
2026 | 6.46 | 14.32% |
2027 | 5.70 | 11.76% |
2028 | 5.06 | 11.23% |
Based on analysts' sales estimates for 2024, the Bayer stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of 1.21 and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of 0.42 .
This results in the following potential growth metrics and future valuations:
Current | 1.20 | 29.82% |
---|---|---|
2024 | 1.21 | 0.95% |
2025 | 1.20 | 0.54% |
2026 | 1.18 | 1.92% |
2027 | 1.17 | 1.39% |
2028 | 1.14 | 2.24% |
Current | 0.42 | 51.17% |
---|---|---|
2024 | 0.42 | 0.86% |
2025 | 0.42 | 0.52% |
2026 | 0.41 | 1.92% |
2027 | 0.40 | 1.39% |
2028 | 0.39 | 2.23% |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.